MED
Get informed when a big investor buys or sells
+ FollowUndervalued by 245.5% based on the discounted cash flow analysis.
| Market cap | $137.72 Million |
|---|---|
| Enterprise Value | $98.68 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.7 |
| Beta | 0.7 |
| Outstanding Shares | 11,135,000 |
| P/E Ratio | -4.98 |
|---|---|
| PEG | 2.21 |
| Price to Sales | 0.43 |
| Price to Book Ratio | 0.71 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | -6.18 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.33 |
| Debt to Equity | 0.17 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 11.47% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 77.75% |
|---|---|
| Total Invested | $15,494▼ 99.98% |
| Investors Holding | 4▼ 116.00% |
No data
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and ...